New study: Capitainer’s technology enables finger-prick self-sampling at home for kidney transplant patients
A new study performed at Oslo University Hospital has validated the usability of Capitainer's pioneering self-sampling device for the standard panel of biomarkers used for monitoring kidney transplanted patients. Capitainer maintained consistent sampling success and analytical quality, generating reliable results regardless of whether the microsampling was performed by healthcare personnel or the patient.Medical technology company Capitainer’s patented sampling products are based on patients taking blood samples, themselves or with assistance, using a unique technology for collecting an